Abbott to receive returned goods of Reductil from pharmacy

Published: 2010-10-22 07:00:00

Updated: 2010-10-22 07:00:00

Abbott Korea has sent a circular letter to proprietors of pharmacy and wholesalers that it will receive returned goods of Reductil (sibutramine), an obesity drug, from the market until November 11 at the latest.

The company already notified healthcare professionals and patients about the volun...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK